Page 47 - MI-2-4
P. 47

Microbes & Immunity                                           Pulmonary immunity: Pathogens versus protectors



               Dhillon NK. Extracellular vesicletors of disease severity and      doi: 10.1080/19490976.2022.2163839
               mortality in patients with severe fever with thrombocytopenia   57.  Johnston SL, Goldblatt DL, Evans SE, Tuvim MJ,
               syndrome. J Extracell Vesicles. 2021;10(9):e12117.
                                                                  Dickey BF. Airway epithelial innate immunity. Front Physiol.
               doi: 10.1002/jev2.12117                            2021;12:749077.
            48.  Ramaswamy A, Brodsky NN, Sumida TS,  et al. Immune      doi: 10.3389/fphys.2021.749077
               dysregulation and autoreactivity correlate with disease   58.  Paradis T, Bègue H, Basmaciyan L, Dalle F, Bon F. Tight
               severity  in  SARS-CoV-2-associated  multisystem   junctions as a key for pathogens invasion in intestinal
               inflammatory  syndrome  in  children.  Immunity.   epithelial cells. Int J Mol Sci. 2021;22(5):2506.
               2021;54(5):1083-1095.e7.
                                                                  doi: 10.3390/ijms22052506
               doi: 10.1016/j.immuni.2021.04.003
                                                               59.  Ishihara N, Tanaka M, Namba K, et al. Long-term exposure
            49.  Mohite P, Yadav V, Pandhare R,  et al. Revolutionizing   to urban particulate matter exacerbates mortality after
               cancer treatment: Unleashing the power of viral vaccines,   ischemic stroke in mice. J Toxicol Sci. 2025;50(3):147-159.
               monoclonal  antibodies,  and  proteolysis-targeting
               chimeras in the new era of immunotherapy. ACS Omega.      doi: 10.2131/jts.50.147
               2024;9(7):7277-7295.                            60.  Hu D, Jia X, Cui L, et al. Exposure to fine particulate matter
               doi: 10.1021/acsomega.3c06501                      promotes platelet activation and thrombosis via obesity-
                                                                  related inflammation. J Hazard Mater. 2021;413:125341.
            50.  Paudyal B, McNee A, Rijal P, et al. Low dose pig anti-influenza
               virus monoclonal antibodies reduce lung pathology but do      doi: 10.1016/j.jhazmat.2021.125341
               not prevent virus shedding. Front Immunol. 2021;12:790918.  61.  Koul A, Bawa RK, Kumar Y. Artificial intelligence techniques
               doi: 10.3389/fimmu.2021.790918                     to predict the airway disorders illness: A systematic review.
                                                                  Arch Computat Methods Eng. 2023;30(2):831-864.
            51.  Li  N,  Parkes  JE,  Spathis  R,  et al.  The  effect  of
               immunomodulatory treatments on anti-dystrophin immune      doi: 10.1007/s11831-022-09818-4
               response after AAV gene therapy in dystrophin deficient   62.  Yan C,  Wang L, Lin  J,  et al. A  fully automatic artificial
               mdx mice. J Neuromuscul Dis. 2021;8(s2):S325-S340.  intelligence-based CT  image analysis  system  for accurate
               doi: 10.3233/JND-210706                            detection, diagnosis, and quantitative severity evaluation of
                                                                  pulmonary tuberculosis. Eur Radiol. 2022;32:2188-2199.
            52.  Xu C, Hao M, Zai X,  et al. A  new perspective on gut-
               lung axis affected through resident microbiome and their      doi: 10.1007/s00330-021-08365-z
               implications on immune response in respiratory diseases.   63.  Mettelman RC, Allen EK, Thomas PG. Mucosal immune
               Arch Microbiol. 2024;206(3):107.                   responses to infection and vaccination in the respiratory
               doi: 10.1007/s00203-024-03843-6                    tract. Immunity. 2022;55(5):749-780.
            53.  Song Z, Meng Y, Fricker M, Tian H, Tan Y, Qin L. The role      doi: 10.1016/j.immuni.2022.04.013
               of gut-lung axis in COPD: Pathogenesis, immune response,   64.  Fraser R, Orta-Resendiz A, Mazein A, Dockrell DH. Upper
               and prospective treatment. Heliyon. 2024;10(9):e30612.  respiratory tract mucosal immunity for SARS-CoV-2
               doi: 10.1016/j.heliyon.2024.e3061                  vaccines. Trends Mol Med. 2023;29(4):255-267.
            54.  De Oliveira GLV, Oliveira CNS, Pinzan CF, De Salis LVV,      doi: 10.1016/j.molmed.2023.01.003
               Cardoso CRB. Microbiota modulation of the gut-lung axis   65.  Jung M, Dourado M, Maksymetz J,  et al. Cross-species
               in COVID-19. Front Immunol. 2021;12:635471.        transcriptomic atlas of dorsal root ganglia reveals species-
               doi: 10.3389/fimmu.2021.635471                     specific programs for sensory function.  Nat Commun.
                                                                  2023;14(1):366.
            55.  Loera-Muro A, Guerrero-Barrera A, Tremblay DNY,
               Hathroubi S, Angulo C. Bacterial biofilm-derived antigens:      doi: 10.1038/s41467-023-36014-0
               A new strategy for vaccine development against infectious   66.  Mogilenko DA, Shpynov O, Andhey PS, et al. Comprehensive
               diseases. Expert Rev Vaccines. 2021;20(4):385-396.  profiling of an aging immune system reveals clonal GZMK+
               doi: 10.1080/14760584.2021.1892492                 CD8+ T cells as conserved hallmark of inflammaging.
                                                                  Immunity. 2021;54(1):99-115.e12.
            56.  Worley MJ. Immune evasion and persistence in enteric
               bacterial pathogens. Gut Microbes. 2023;15(1):2163839.     doi: 10.1016/j.immuni.2020.11.005








            Volume 2 Issue 4 (2025)                         39                           doi: 10.36922/MI025100019
   42   43   44   45   46   47   48   49   50   51   52